Related Experiment Videos

Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria

M F Hofer1, R Mouy, A M Prieur

  • 1Centre Multisite Romand de Rhumatologie Pédiatrique, Département de Pédiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. michael.hofer@chuv.hospvd.ch

Insights

A new classification for juvenile idiopathic arthritis (JIA) was evaluated in children. While 80% of patients fit a category, adjustments are needed for better diagnostic clarity in pediatric rheumatology.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Child Health

Background:

  • Chronic arthritis in children is a diverse group of diseases with unclear causes.
  • The International League Against Rheumatism developed new criteria for classifying these conditions.
  • Accurate classification is crucial for understanding and managing pediatric arthritis.

Purpose of the Study:

  • To analyze the applicability of the new International League Against Rheumatism classification criteria in children with chronic arthritis.
  • To assess the diagnostic utility of the proposed criteria in a pediatric cohort.
  • To identify areas for improvement in the classification system.

Main Methods:

  • A prospective cohort of children with chronic arthritis was sequentially examined.
  • Patients were evaluated in a pediatric rheumatology clinic setting.
  • The study included 194 children who met the criteria for juvenile idiopathic arthritis.

Main Results:

  • 155 out of 194 children (80%) were successfully classified into one of the six diagnostic categories.
  • 17 children (9%) did not fit any category, and 22 (11%) fit into multiple categories.
  • Psoriatic arthritis and enthesitis-related arthritis showed lower rates of single-category classification compared to others.

Conclusions:

  • The proposed classification is a valuable tool for diagnosing chronic arthritis in children.
  • Modifications to the criteria are recommended to enhance the percentage of patients classified into a single, defined category.
  • Further refinement is necessary to optimize the diagnostic accuracy and utility of the classification system.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History